Zoetis
ZTS
$174.61
Share price
3.22%
Change (1 day)
-6.18%
Change (1 year)
Categories
Revenue for Zoetis (ZTS)
Revenue in 2022 (TTM): $7.89 B
According to Zoetis's latest financial reports the company's current revenue (TTM) is $7.89 B. In 2021 the company made a revenue of $7.77 B an increase over the years 2020 revenue that were of $6.67 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Zoetis from 2011 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $7.89 B | 1.48% |
| 2021 | $7.77 B | 16.49% |
| 2020 | $6.67 B | 6.63% |
| 2019 | $6.26 B | 7.47% |
| 2018 | $5.82 B | 9.76% |
| 2017 | $5.30 B | 8.57% |
| 2016 | $4.88 B | 2.58% |
| 2015 | $4.76 B | -0.42% |
| 2014 | $4.78 B | 4.91% |
| 2013 | $4.56 B | 5.19% |
| 2012 | $4.33 B | 2.43% |
| 2011 | $4.23 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $92.36 B | 1,070.54% | 🇺🇸 USA |
 Eli Lilly LLY | $29.32 B | 271.60% | 🇺🇸 USA |
 Sanofi SNY | $44.62 B | 465.53% | 🇫🇷 France |
 Merck MRK | $53.97 B | 584.05% | 🇺🇸 USA |
 Phibro Animal Health
PAHC | $0.90 B | -88.50% | 🇺🇸 USA |
 Kindred Biosciences
KIN | $7.92 M | -99.90% | 🇺🇸 USA |
 Heska Corporation
HSKA | $0.25 B | -96.73% | 🇺🇸 USA |